Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA
stevepb / Pixabay

Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA

According to a story from Ankylosing Spondylitis News, the drug Hadlima, which is a biosimilar to the drug Humira (adalimumab), was recently approved by the US Food and Drug Administration…

Continue Reading Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA
Estela Lugo of the Hereditary Neuropathy Foundation Seeks to Raise Charcot-Marie-Tooth Disease Awareness
harpenz / Pixabay

Estela Lugo of the Hereditary Neuropathy Foundation Seeks to Raise Charcot-Marie-Tooth Disease Awareness

According to a story from Charcot-Marie-Tooth Disease News, Charcot-Marie-Tooth disease is actually somewhat common in the US compared to other rare diseases. In fact, it is estimated that around 150,000…

Continue Reading Estela Lugo of the Hereditary Neuropathy Foundation Seeks to Raise Charcot-Marie-Tooth Disease Awareness
FDA Grants Regenerative Medicine Advanced Therapy Designation to Experimental Wiskott-Aldrich Syndrome Drug
stevepb / Pixabay

FDA Grants Regenerative Medicine Advanced Therapy Designation to Experimental Wiskott-Aldrich Syndrome Drug

According to a press release from the British-American biopharmaceutical company Orchard Therapeutics, the American Food and Drug Administration (FDA) has granted OTL-103, the Company's experimental Wiskott-Aldrich Syndrome drug, Regenerative Medicine…

Continue Reading FDA Grants Regenerative Medicine Advanced Therapy Designation to Experimental Wiskott-Aldrich Syndrome Drug
First Patient Registered for Phase 3 Multiple System Atrophy Clinical Trial
mwooten / Pixabay

First Patient Registered for Phase 3 Multiple System Atrophy Clinical Trial

According to a story from PR Newswire, the biopharmaceutical company Biohaven Pharmaceutical Holding Company, Ltd. has announced that the first patient has signed up for the company's phase 3 clinical…

Continue Reading First Patient Registered for Phase 3 Multiple System Atrophy Clinical Trial
Immunocore and Pulse Infoframe Lend Support to International Uveal Melanoma Patient Registry
Source: Pixabay

Immunocore and Pulse Infoframe Lend Support to International Uveal Melanoma Patient Registry

According to a press release from British biotechnology company Immunocore, the Company has partnered with Pulse Infoframe (a Canadian data analytics company) to support the development of an international database…

Continue Reading Immunocore and Pulse Infoframe Lend Support to International Uveal Melanoma Patient Registry
Close Menu